Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or Lupus-like disease

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 6, 2012, Pages 914-925

  Salvatore, Steven P ^a   Barisoni, Laura M C ^b   Herzenberg, Andrew M ^c   Chander, Praveen N ^d   Nickeleit, Volker ^e   Seshan, Surya V ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLLAPSING GLOMERULOPATHY; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; GLOMERULOPATHY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; LUPUS LIKE SYNDROME; MALE; MESANGIUM CELL; NEPHROTIC SYNDROME; PROGNOSIS; PROTEINURIA; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ATROPHY; BIOPSY; DISEASE PROGRESSION; FEMALE; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; KIDNEY TUBULES; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PROTEINURIA; PULSE THERAPY, DRUG; RETROSPECTIVE STUDIES; STEROIDS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862204647     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.11751111     Document Type: Article

References (48)

1. Valeri A, Barisoni L, Appel GB, Seigle R, D'Agati V: Idiopathic collapsing focal segmental glomerulosclerosis: A clinicopathologic study. Kidney Int 50: 1734-1746, 1996
2. Laurinavicius A, Hurwitz S, Rennke HG: Collapsing glomerulopathy in HIV and non-HIV patients: A clinicopathological and follow-up study. Kidney Int 56: 2203-2213, 1999
3. D'Agati VD, Fogo AB, Bruijn JA, Jennette JC: Pathologic classification of focal segmental glomerulosclerosis: A working proposal. Am J Kidney Dis 43: 368-382, 2004
4. Albaqumi M, Soos TJ, Barisoni L, Nelson PJ: Collapsing glomerulopathy. J Am Soc Nephrol 17: 2854-2863, 2006
5. Markowitz GS, Nasr SH, Stokes MB, D'Agati VD: Treatment with IFN-alpha,-beta, or-gamma is associated with collapsing focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 5: 607-615, 2010
6. Bariety J, Mandet C, Hill GS, Bruneval P: Parietal podocytes in normal human glomeruli. J Am Soc Nephrol 17: 2770-2780, 2006
7. Barisoni L, Kriz W, Mundel P, D'Agati V: The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 10: 51-61, 1999
8. Smeets B, Uhlig S, Fuss A, Mooren F, Wetzels JFM, Floege J, Moeller MJ: Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J Am Soc Nephrol 20: 2604-2615, 2009
9. Marques LP, Pacheco GG, Rioja LS, Nunes SN, Velone ST, Santos OR: Can systemic lupus erythematosus be the cause of collapsing glomerulopathy? Lupus 14: 853-855, 2005
10. Hertig A, Droz D, Lesavre P, Grünfeld J-P, Rieu P: SLE and idiopathic nephrotic syndrome: Coincidence or not? AmJ KidneyDis 40: 1179-1184, 2002
11. Amoura Z, Georgin-Lavialle S, Haroche J, Merrien D, Brocheriou I, Beaufils H, Piette J-C: Collapsing glomerulopathy in systemic autoimmune disorders: A case occurring in the course of full blown systemic lupus erythematosus. Ann Rheum Dis 65: 277-278, 2006
12. Arbel O, Pizov G, Ben-Yehuda A, Rubinow A, Naparstek Y, Amital H: Hyperacute renal failure as the initial presentation of systemic lupus erythematosus. Lupus 14: 331-333, 2005
13. Avila-Casado MC, Vargas-Alarcon G, Soto ME, Hernandez G, Reyes PA, Herrera-Acosta J: Familial collapsing glomerulopathy: Clinical, pathological and immunogenetic features. Kidney Int 63: 233-239, 2003
14. Kraft SW, Schwartz MM, Korbet SM, Lewis EJ: Glomerular podocytopathy in patients with systemic lupus erythematosus. J Am Soc Nephrol 16: 175-179, 2005
15. Melo NC, Malheiros DM, Barros RT, Woronik V: Collapsing glomerulopathy associated with proliferative lupus nephritis: Reversible acute kidney injury. Lupus 20: 98-101, 2011
16. Rifkin SI, Gutta H, Nair R, McFarren C, Wheeler DE: Collapsing glomerulopathy in a patient with mixed connective tissue disease. Clin Nephrol 75[Suppl 1]: 32-36, 2011
17. Gupta R, Sharma A, Bhowmik D, Gupta S, Agarwal S, Gupta R, Dinda A: Collapsing glomerulopathy occurring in HIV-negative patientswith systemic lupus erythematosus: Report of three cases and brief review of the literature. Lupus 20: 866-870, 2011
18. Tungekar MF, Waller S, Clothier JC: Collapsing glomerulopathy in a girl with systemic lupus erythematosus. Pediatr Nephrol 26: 809-813, 2011
19. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1277, 1982
20. Albaqumi M, Barisoni L: Current views on collapsing glomerulopathy. J Am Soc Nephrol 19: 1276-1281, 2008
21. Detwiler RK, Falk RJ, Hogan SL, Jennette JC: Collapsing glomerulopathy: A clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 45: 1416-1424, 1994
22. Cohen AH, Sun NC, Shapshak P, Imagawa DT: Demonstration of human immunodeficiency virus in renal epithelium in HIVassociated nephropathy. Mod Pathol 2: 125-128, 1989
23. Kimmel PL, Ferreira-Centeno A, Farkas-Szallasi T, Abraham AA, Garrett CT: Viral DNA in microdissected renal biopsy tissue from HIV infected patients with nephrotic syndrome. Kidney Int 43: 1347-1352, 1993
24. Moudgil A, Nast CC, Bagga A, Wei L, Nurmamet A, Cohen AH, Jordan SC, Toyoda M: Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int 59: 2126-2133, 2001
25. Markowitz GS, Appel GB, Fine PL, Fenves AZ, Loon NR, Jagannath S, Kuhn JA, Dratch AD, D'Agati VD: Collapsing focal segmental glomerulosclerosis following treatment with highdose pamidronate. J Am Soc Nephrol 12: 1164-1172, 2001
26. Laurinavicius A, Rennke HG: Collapsing glomerulopathy-a new pattern of renal injury. Semin Diagn Pathol 19: 106-115, 2002
27. Dayal AK, Kammer GM: The T cell enigma in lupus. Arthritis Rheum 39: 23-33, 1996
28. Lo M, Tsokos G: T cells in systemic lupus erythematosus: Progress toward targeted therapy. Rheumatologist Available online at www.the-rheumatologist.org/details/1311767/T_cells_in_Systemic_ Lupus_Erythematosus.html. Accessed August 16, 2011
29. Hickman PL, Nolph KD, Jacobs R, Luger AM, Walker SE: Idiopathic focal segmental glomerulosclerosis in a patient with systemic lupus erythematosus: An unusual combination. Am J Kidney Dis 23: 582-586, 1994
30. Baranowska-Daca E, Choi Y-J, Barrios R, Nassar G, Suki WN, Truong LD: Nonlupus nephritides in patients with systemic lupus erythematosus: A comprehensive clinicopathologic study and review of the literature. Hum Pathol 32: 1125-1135, 2001
31. Nishihara G, Nakamoto M, Yasunaga C, Takeda K, Matsuo K, Urabe M, Goya T, Sakemi T: Systemic lupus erythematosus in a patient with remitting minimal change nephrotic syndrome. Clin Nephrol 48: 327-330, 1997
32. Dube GK, Markowitz GS, Radhakrishnan J, Appel GB, D'Agati VD: Minimal change disease in systemic lupus erythematosus. Clin Nephrol 57: 120-126, 2002
33. Avila-Casado MC, Perez-Torres I, Auron A, Soto V, Fortoul TI, Herrera-Acosta J: Proteinuria in rats induced by serum from patients with collapsing glomerulopathy. Kidney Int 66: 133-143, 2004
34. Smeets B, Te Loeke NAJM, Dijkman HBPM, Steenbergen MLM, Lensen JFM, Begieneman MPV, van Kuppevelt TH, Wetzels JFM, Steenbergen EJ: The parietal epithelial cell: a key player in the pathogenesis of focal segmental glomerulosclerosis in Thy-1.1 transgenic mice. J Am Soc Nephrol 15: 928-939, 2004
35. CIP1/WAF1 limits glomerular epithelial cell proliferation in experimental glomerulonephritis. Kidney Int 55: 2349-2361, 1999
36. Matsusaka T, Xin J, Niwa S, Kobayashi K, Akatsuka A, Hashizume H, Wang QC, Pastan I, Fogo AB, Ichikawa I: Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury. J AmSoc Nephrol 16: 1013-1023, 2005
37. Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap H-K, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J: Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17: 952-960, 2011
38. El Karoui K, Hill GS, Karras A, Moulonguet L, Caudwell V, Loupy A, Bruneval P, Jacquot C, Nochy D: Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies. Kidney Int 79: 643-654, 2011
39. Ray PE, Xu L, Rakusan T, Liu X-H: A 20-year history of childhood HIV-associated nephropathy. Pediatr Nephrol 19: 1075-1092, 2004
40. Ross MJ, Klotman PE: HIV-associated nephropathy. AIDS 18: 1089-1099, 2004
41. Winston JA, Burns GC, Klotman PE: The human immunodeficiency virus (HIV) epidemic and HIV-associated nephropathy. Semin Nephrol 18: 373-377, 1998
42. Thomas DB, Franceschini N, Hogan SL, Ten Holder S, Jennette CE, Falk RJ, Jennette JC: Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int 69: 920-926, 2006
43. Laradi A, Mallet A, Beaufils H, Allouache M, Martinez F: HIVassociated nephropathy: Outcome and prognosis factors. Groupe d' Etudes Néphrologiques d'Ile de France. J AmSoc Nephrol 9: 2327-2335, 1998
44. Williams DI, Williams DJ, Williams IG, Unwin RJ, Griffiths MH, Miller RF: Presentation, pathology, and outcome of HIV associated renal disease in a specialist centre forHIV/AIDS. Sex Transm Infect 74: 179-184, 1998
45. Freedman BI, Soucie JM, Stone SM, Pegram S: Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy. Am J Kidney Dis 34: 254-258, 1999
46. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Oleksyk T, McKenzie LM, Kajiyama H, Ahuja TS, Berns JS, Briggs W, Cho ME, Dart RA, Kimmel PL, Korbet SM, Michel DM, Mokrzycki MH, Schelling JR, Simon E, Trachtman H, Vlahov D, Winkler CA: MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 40: 1175-1184, 2008
47. Genovese G, Tonna SJ, Knob AU, Appel GB, Katz A, Bernhardy AJ, Needham AW, Lazarus R, PollakMR:Arisk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney Int 78: 698-704, 2010
48. Fessel WJ: Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med 134: 1027-1035, 1974